Skip to main content

Month: July 2021

Ninety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene Therapies for Lung Diseases

NEW YORK, July 18, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, presented 90-day survival outcomes from the 222-patient randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS) at an invited presentation on July 17 to the International Society for Cell & Gene Therapy (ISCT) Scientific Signatures Series on Cell and Gene Therapies in Lung Diseases and Critical Illnesses. The results showed that two doses of remestemcel-L at days 3-5 conferred durable survival benefit through at least 90 days in the pre-specified subgroup of patients under age 65. Key presentation findings were:Remestemcel-L significantly reduced mortality by 48% at 90 days...

Continue reading

Capgemini Press Release// Capgemini announces proposal to acquire Australian cloud transformation and digital services provider, Empired

Media relations:Sam ConnattyTel.: +44 (0)370 904 3601sam.connatty@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini announces proposal to acquire Australian cloud transformation and digital services provider, Empired The acquisition of Empired would significantly increase the size of the Capgemini business in Australia and New Zealand and position it as a market leader in digital, data and cloud across the region Paris, Sydney, July 19, 2021 – Capgemini announces that it has entered into a Scheme Implementation Agreement with Empired Limited (ASX: EPD) to acquire Empired under an Australian statutory shareholder approved process (Scheme). With more than 1000 professionals in Australia and New Zealand, this acquisition would strengthen Capgemini’s capabilities in cloud and...

Continue reading

Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021

VANCOUVER, British Columbia, July 17, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc. (“Vocan”) will be presenting at a Company hosted Virtual Town Hall meeting on Wednesday, August 4, 2021 at 1:30 p.m. PST/ 4:30 p.m. ET/ 22:30 p.m. CET. The Virtual Town Hall event will comprise of a presentation by Dr. Hancock on the status of Vocan’s production of biosynthetic psilocybin and will include live video from the Company’s operating laboratory in Victoria, British Columbia. Dr. Hancock will also be answering questions from investors. “2021 has been a significant year for Core One Labs, and our teams have been very...

Continue reading

ECMOHO Announces Strategic Cooperation Agreement with South Korean ChongKunDang Group to Establish Distribution of High-End Health Foods

SHANGHAI, China, July 16, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, is pleased today to announce a strategic cooperation agreement with well-known South Korean pharmaceutical company, ChongKunDang Group (hereafter referred to as “CKD”), in providing global marketing and multichannel sales for one-stop retail solutions for CKD’s health products in China. With advanced equipment and cutting-edge technology as its foundation, CKD will be able to provide Chinese consumers with high-quality, diversified healthcare products, including probiotics, via ECMOHO’s established and extensive domestic distribution channels. ECMOHO, as a leading online retail service provider of health products in China, has cooperated...

Continue reading

Ammonia Market to Reach USD 110.93 Billion by 2028; Essentiality of NH3 in Fertilizer Production to Foster Enduring Market Growth, Says Fortune Business Insights™

Key companies covered in the ammonia market are Rashtriya Chemicals and Fertilizers Limited (RCFL) (Mumbai, India), Praxair Technology, Inc. (Connecticut, the U.S.), EuroChem Group (Zug, Switzerland), SABIC (Riyadh, Saudi Arabia), CF Industries Holdings, Inc. (Illinois, the U.S.), Yara International ASA (Oslo, Norway), China National Petroleum Corporation (Beijing, China), Koch Fertilizer, LLC (Kansas, the U.S.), Qatar Petroleum (Doha, Qatar), Nutrien Ltd. (Saskatoon, Canada), BASF SE (Ludwigshafen, Germany) and more players profiled Pune, India, July 16, 2021 (GLOBE NEWSWIRE) — The global ammonia market size is projected to reach USD 110.93 billion by 2028, exhibiting a CAGR of 6.4%during the forecast period. As per the report by Fortune Business Insights™, titled “Ammonia Market, 2021-2028”, the market’s value was estimated to...

Continue reading

Monmouth Real Estate Investment Corporation Announces Receipt of Amendment to Unsolicited Acquisition Proposal

No Action Needs to be Taken by Monmouth Shareholders at This Time HOLMDEL, N.J., July 16, 2021 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE: MNR, “Monmouth” or “the Company”) today announced that it received an amendment to the unsolicited acquisition proposal it previously received on July 8, 2021 from a certain large private investment firm. The amendment to the proposal reflects an increase of $0.18 per share in the consideration that would be paid for each share of Monmouth Common Stock, resulting in a net cash consideration of $18.88 per share, reflecting a stated purchase price of $19.51 per share reduced by the termination fee of approximately $62.2 million, or $0.63 per share, if Monmouth terminates the merger agreement it previously entered into with Equity Commonwealth (“EQC”) in accordance with...

Continue reading

Ayr Wellness to Hold Second Quarter 2021 Conference Call on Tuesday, August 17, 2021 at 8:30 a.m. ET

NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, will hold a conference call on Tuesday, August 17, 2021 at 8:30 a.m. ET to discuss its results for the second quarter ended June 30, 2021. Ayr CEO Jonathan Sandelman, co-COOs Jennifer Drake and Jason Griffith, and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call.CONFERENCE CALL DATE: Tuesday, August 17, 2021TIME: 8:30 a.m. Eastern timeTOLL-FREE DIAL-IN NUMBER: (800) 319-4610INTERNATIONAL DIAL-IN NUMBER: (604) 638-5340WEBCAST: The conference call will be broadcast live and available for replay here: https://www.gowebcasting.com/11437REPLAY: A...

Continue reading

CapStar’s Mark Niethammer Selected to Participate in National GGL Leadership Program

Mark NiethammerMark Niethammer, CapStar BankNASHVILLE, Tenn., July 16, 2021 (GLOBE NEWSWIRE) — Mark Niethammer, Director of Government Guaranteed Lending at CapStar Bank, was recently selected to participate in the National Association of Government Guaranteed Lender’s (NAGGL) inaugural Future Leading Lenders Program (FLLP). From 50 eligible candidates nationwide, Niethammer is one of only twelve selected to participate. The interactive FLLP experience is intended to recognize and develop the next generation of 7(a) industry leaders who are building or expanding their SBA teams. The best in class program is geared toward broadening expertise and deepening engagement. The curriculum consists of four modules spanning nine months, including opportunities to attend flagship NAGGL events and culminating with program...

Continue reading

VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.22 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM

NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) — Value Line, Inc., (NASDAQ: VALU) announced today that its Board of Directors declared on July 16, 2021, a quarterly cash dividend of $0.22 per common share, payable on August 11, 2021, to stockholders of record on July 26, 2021.  The Board of Directors also on July 16, 2021 approved a renewal of the share repurchase program, effective immediately, allowing the repurchase of shares from time to time, up to an aggregate amount of $2,000,000. The Company, under the previous program, announced in April 2020, has purchased 58,880 shares and expended $1,686,324 of the authorized $2,000,000 initial amount by July 2, 2021. The new repurchase program has no set price limit and no expiration date. “Based on the Company’s current financial results, we believe that renewal of the repurchase...

Continue reading

Brookfield Infrastructure Completes Sale of North American District Energy Business for $4.1 Billion

BROOKFIELD, NEWS, July 16, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announces that it has completed the sale of 100% of its North American district energy business, Enwave. The business has been divested through two separate transactions for total consideration of $4.1 billion on an enterprise value basis. Enwave’s Canadian business was acquired by Ontario Teachers’ Pension Plan Board and IFM Investors on June 7, 2021, and Enwave’s U.S. business was acquired by QIC and Ullico on July 16, 2021. Net proceeds to BIP are approximately $1 billion. We have earned an IRR of over 30% on our investment and a multiple of invested capital of over six times. Brookfield Infrastructure made its first district energy investment in 2012 and subsequently developed the business into the largest district energy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.